Member Info for Lawson

Thank you, Perhaps I should explain, I invested this share from an article about MTFB in an investment magazine in February. Since then I have read all I could find without a great understanding of what I was reading. Your post, I S and IW have been extremely helpful in clarifying the situation re trials etc.

I too have made some pretty awful investments, how this turns out remains to be seen.
Thank you anyway for your very satisfactory and in depth answer. For a regular “John/ Jane doe”
Your powers of research and analysis are far beyond mine.

I and possibly others, without your medical knowledge would welcome your interpretation of those facts, should you wish to share them. Doing research is near impossible when you don't fully understand the implications of what you are reading.

Thank you and have a fun weekend.

Good evening Ivy. I am going to have to admit that your post has gone right over my head. Is this good, bad or indifferent news for Iclaprin and it's future?

The Media no longer print news they drive it and love a little hyperbole to create a negative and desperate story and share prices suffer the consequences.
This will recover as the day goes on and the dust settles then hopefully we will get some reasonable news from the bod to help the sp..

I am hoping this will climb back up on receipt of a new funding RNS and possibly some sale offers.

Someone loses a lot of money on these shares but it happens to quite a lot of us and we mostly just put it behind us and invest in something else. That is the game we play.
I felt sorry for SP being so bitter and twisted and all but not any more, He has earned the title of village idiot with his comedy posts.
Anyway nobody knows what the future holds but I sure hope for the best.

No Ian.B didn't say anything about approval, he was paraphrasing and ridiculing (quite rightly) another poster on this BB

As stated in the announcement on 11 April 2019, the Board's view remains that the Company will require material further equity and/or debt funding. It is likely that such funding will be required by the end of June 2019. Without such funding, the Company is unlikely to be able to continue as a going concern. ( From the last RNS)

I am no longer invested here but I thought you all might find this interesting. Good luck.https://news.sky.com/story/virgin-atlantic-flies-into-dogfight-over-thomas-cook-airline-11715547

good find Ian B thanks. I,nteresting positive interview . Which of the 4 options will it be. Hopefully a label change, time as ever, will tell!

Distant future, there you go The Italian and forgive the plagiarism but that is a much improved header.

I couldn't care less what the CEO and BOD does or doesn't invest in and I can't see why you are being so pedantic in your constant posts.

All I care about is that they have done a proper job so that Iclaprin can hit the market and be an excellent medical benefit for those that need it and an excellent benefit for us the investors and that is all we should care about not the market movements at this stage how because nobody really knows anything at all.

Normal day in the US tomorrow, no public holiday so yes, Nasdaq trading as usual.

Lamellar's candidate LMS-611, which has mucus clearing properties, had demonstrated the enhancement of certain properties of antibiotics and had European orphan drug designation for CF.

'The companies believe that, based on pre-clinical data with the two individual components, the combination could be a promising potential treatment for lung infections in patients with CF,' Motif Bio said. (Taken from shares magazine)

We should hear something from the FDA within 30 days and you will see many possible prices thrown into the ring but nobody really knows.. the only thing beyond contestation is the the share price will rise significantly if this gains FDA approval.

Not without some more good news it won't.

And when he goes to the nearest Bar afterwards, will it be Champagne or a whisky bottle!!

That the up momentum continues but I have noticed that this share has short sharp spikes after a good RNS then drops back afterwords. We need contracts to really get this back up.

I am more than happy to say I wrote to soon. Phew!!